Hotel California “A Salute to the Eagles” to play concert at The Hormel Institute
Inspired by recent advances and new technologies, the U’s largest donor provides a major influx of funding to cancer research at the Masonic Cancer Center, University of Minnesota
In the Land of 10,000 Lakes, cancer—Minnesota’s leading cause of death—will affect half of us directly and the rest of us through people we know and love.
Led by the Masonic Cancer Center, University of Minnesota, the network is funded in partnership with the State of Minnesota
Led by renowned cancer researchers, Dorothy Hatsukami, PhD, and Stephen Hecht, PhD, a new study out of the University of Minnesota will be focused on cancer risk in firefighters, thanks to a new partnership between the Masonic Cancer Center, University of Minnesota and the Minnesota Firefighters Foundation.
The idea for this study came from current firefighter and MNFFF.org board member, Kelly Piller, who saw a similar research project in action with colleagues in Florida.
The Rein in Sarcoma Foundation announced four recipients of their 2018 Sarcoma Research Grants. This is the 18th year that Rein in Sarcoma has provided grants to the University of Minnesota, with this year's contribution totaling $148,000.
Awardees for 2018 and their research are:
Amy Skubitz, PhD - Predicting Relapse and Response to Chemotherapy in Sarcoma
Aaron Sarver, PhD - Retrospective and Prospective Comparison of Prognostic Transcriptional Biomarkers in Osteosarcoma using NanoString RNA profiling
The Vince Lombardi Cancer Foundation recently honored four 'Leaders for A Cure' at a Super Bowl related event in St. Paul, MN on February 1.
Among the honorees was Chris Pennell, PhD, the Masonic Cancer Center's Associate Director of Community Engagement and Education, and Judy Erdahl, a University of Minnesota supporter and creator of the Midwest Metastatic Breast Cancer Conference.
The following Masonic Cancer Center members were recently awarded Shaver Fund Awards from the Randy Shaver Cancer Research and Community Fund.
Venkatram Mereddy, PhD - New Drugs for the Treatment of Glioblastoma and Breast Cancer Metastasis to Brain
Henry Balfour, MD - A Vaccine Against the First Human Cancer Virus: Epstein-Barr Virus (EBV)
Martin Felices, PhD and Melissa Geller MD, MS - Maximizing Natural Killer Cell Immunotherapy in Ovarian Cancer